APA (7th ed.) Citation

Akar, Z. A., Yıldırım, D., Çiftçi, M., Işık Sula, Z., Karaman, S., Çevik, R., . . . Çağlayan, M. (2026). Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis. Diagnostics (2075-4418), 16(6), 957. https://doi.org/10.3390/diagnostics16060957

Chicago Style (17th ed.) Citation

Akar, Zeynel Abidin, et al. "Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis." Diagnostics (2075-4418) 16, no. 6 (2026): 957. https://doi.org/10.3390/diagnostics16060957.

MLA (9th ed.) Citation

Akar, Zeynel Abidin, et al. "Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis." Diagnostics (2075-4418), vol. 16, no. 6, 2026, p. 957, https://doi.org/10.3390/diagnostics16060957.